PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 214 filers reported holding PDL BIOPHARMA INC in Q1 2015. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $53,000 | -59.5% | 18,708 | -51.4% | 0.01% | -52.4% |
| Q3 2017 | $131,000 | +29.7% | 38,458 | +19.6% | 0.02% | -22.2% |
| Q2 2016 | $101,000 | -52.1% | 32,160 | -49.0% | 0.03% | -52.6% |
| Q1 2016 | $211,000 | +36.1% | 63,119 | +44.4% | 0.06% | +21.3% |
| Q4 2015 | $155,000 | +56.6% | 43,705 | +210.7% | 0.05% | +9.3% |
| Q1 2015 | $99,000 | – | 14,067 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KESTREL INVESTMENT MANAGEMENT CORP | 1,465,000 | $3,853,000 | 1.56% |
| SMH CAPITAL ADVISORS INC | 93,708 | $246,000 | 0.42% |
| West Family Investments, Inc. | 627,800 | $1,651,000 | 0.39% |
| KENNEDY CAPITAL MANAGEMENT LLC | 7,082,858 | $18,628,000 | 0.35% |
| ARMISTICE CAPITAL, LLC | 1,800,000 | $4,734,000 | 0.28% |
| BRANDES INVESTMENT PARTNERS, LP | 3,936,719 | $10,354,000 | 0.23% |
| ROCKY MOUNTAIN ADVISERS, LLC | 14,300 | $38,000 | 0.13% |
| Zebra Capital Management LLC | 74,695 | $196,000 | 0.09% |
| Connor, Clark & Lunn Investment Management Ltd. | 5,968,105 | $15,696,000 | 0.09% |
| CREDIT AGRICOLE S A | 471,644 | $1,240,000 | 0.06% |